BSX · Boston Scientific Corp · Share Buybacks
$43.65
-0.23 (-0.52%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$63.59B
Shares
1.45B
Volume · Sep 30
17.97M
Avg daily vol (3M)
19.98M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$5,000,000,000
as of 2026-06-30
Remaining Authorization
$3,000,000,000
as of 2026-06-30
Program Utilization
40.0%
$2,000,000,000 used of $5,000,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2022-12-31 | $0 | 10-K, filed 2023-02-23 |
| 2021-12-31 | $0 | 10-K, filed 2023-02-23 |
| 2020-12-31 | $535,000,000 | 10-K, filed 2023-02-23 |
| 2019-12-31 | $0 | 10-K, filed 2022-02-23 |
| 2018-12-31 | $0 | 10-K, filed 2021-02-23 |
| 2016-12-31 | $0 | 10-K, filed 2017-02-23 |
| 2015-12-31 | $0 | 10-K, filed 2017-02-23 |
| 2014-12-31 | $125,000,000 | 10-K, filed 2017-02-23 |
| 2013-12-31 | $500,000,000 | 10-K, filed 2016-02-24 |
| 2012-12-31 | $600,000,000 | 10-K, filed 2015-02-25 |
| 2011-12-31 | $492,000,000 | 10-K, filed 2014-02-26 |
Key facts
CIK
885725
CUSIP
101137107
13F (30d)
43 filings
27 filers
Visit website
Investor relations